Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Parkman Healthcare Partners LLC Stock Portfolio

$815Million– No. of Holdings #99

Parkman Healthcare Partners LLC Performance:
2024 Q1: 8.57%YTD: 8.57%2023: 7.05%

Performance for 2024 Q1 is 8.57%, and YTD is 8.57%, and 2023 is 7.05%.

About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings

Parkman Healthcare Partners LLC is a hedge fund based in STAMFORD, CT. On 27-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $591.9 Millions. In it's latest 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $815 Millions as of 31 Mar, 2024.

The top stock holdings of Parkman Healthcare Partners LLC are THC, UTHR, BSX. The fund has invested 3.7% of it's portfolio in TENET HEALTHCARE CORP and 3.6% of portfolio in UNITED THERAPEUTICS CORP DEL.

The fund managers got completely rid off COOPER COS INC (COO), AMGEN INC (AMGN) and QIAGEN NV (QGEN) stocks. They significantly reduced their stock positions in CULLINAN ONCOLOGY INC (CGEM), INTRA-CELLULAR THERAPIES INC (ITCI) and KEROS THERAPEUTICS INC (KROS). Parkman Healthcare Partners LLC opened new stock positions in COOPER COS INC (COO), ELI LILLY & CO (LLY) and FORTREA HLDGS INC. The fund showed a lot of confidence in some stocks as they added substantially to IRONWOOD PHARMACEUTICALS INC (IRWD), STANDARD BIOTOOLS INC (LAB) and SCHRODINGER INC (SDGR).
Parkman Healthcare Partners LLC Equity Portfolio Value
Last Reported on: 15 May, 2024

Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Parkman Healthcare Partners LLC made a return of 8.57% in the last quarter. In trailing 12 months, it's portfolio return was 20.89%.

New Buys

Ticker$ Bought
cooper cos inc28,956,600
eli lilly & co24,985,700
fortrea hldgs inc17,172,100
qiagen nv13,496,900
oscar health inc12,361,200
hca healthcare inc11,767,900
livanova plc8,111,300
elevance health inc7,863,140

New stocks bought by Parkman Healthcare Partners LLC

Reductions

Ticker% Reduced
cullinan oncology inc-66.33
intra-cellular therapies inc-62.48
keros therapeutics inc-50.53
merus n v-49.23
ideaya biosciences inc-49.08
vaxcyte inc-43.96
insmed inc-38.31
boston scientific corp-34.82

Parkman Healthcare Partners LLC reduced stake in above stock

Sold off

Ticker$ Sold
somalogic inc-2,251,950
black diamond therapeutics i-712,945
qiagen nv-10,857,500
neogenomics inc-3,846,990
supernus pharmaceuticals inc-3,455,930
aslan pharmaceuticals ltd-57,775
immunic inc-153,384
liquidia corporation-1,224,260

Parkman Healthcare Partners LLC got rid off the above stocks

Sector Distribution

Parkman Healthcare Partners LLC has about 89.2% of it's holdings in Healthcare sector.

Sector%
Healthcare89.2
Others10.2

Market Cap. Distribution

Parkman Healthcare Partners LLC has about 36% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
SMALL-CAP31.9
LARGE-CAP31.8
MID-CAP20.5
UNALLOCATED7.2
MEGA-CAP4.2
MICRO-CAP2.9
NANO-CAP1.5

Stocks belong to which Index?

About 67.1% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 200044.3
Others33
S&P 50022.8
Top 5 Winners (%)%
VKTX
viking therapeutics inc
126.5 %
VTYX
ventyx biosciences inc
122.7 %
LBPH
longboard pharmaceuticals in
82.4 %
INZY
inozyme pharma inc
76.8 %
EWTX
edgewise therapeutics inc
66.5 %
Top 5 Winners ($)$
THC
tenet healthcare corp
9.5 M
KROS
keros therapeutics inc
8.3 M
LBPH
longboard pharmaceuticals in
6.8 M
BSX
boston scientific corp
6.4 M
RXST
rxsight inc
5.5 M
Top 5 Losers (%)%
CVRX
cvrx inc
-37.3 %
AUGX
augmedix inc
-29.3 %
IRWD
ironwood pharmaceuticals inc
-29.2 %
TKNO
alpha teknova inc
-28.4 %
SIBN
si-bone inc
-21.7 %
Top 5 Losers ($)$
PODD
insulet corp
-4.1 M
CVRX
cvrx inc
-3.6 M
SDGR
schrodinger inc
-3.6 M
IRWD
ironwood pharmaceuticals inc
-3.1 M
AUGX
augmedix inc
-1.8 M

Parkman Healthcare Partners LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Parkman Healthcare Partners LLC

Parkman Healthcare Partners LLC has 99 stocks in it's portfolio. About 31.5% of the portfolio is in top 10 stocks. PODD proved to be the most loss making stock for the portfolio. THC was the most profitable stock for Parkman Healthcare Partners LLC last quarter.

Last Reported on: 15 May, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions